C
PACB icon

Covestor’s Pacific Biosciences PACB Stock Holding History

Covestor’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
147
+104
+242% +$151 ﹤0.01% 2751
2026
Q1 		$0 Hold
43
– – ﹤0.01% 2641
2025
Q4 		$0 Sell
43
-1
-2% -$2 ﹤0.01% 2615
2025
Q3 		$0 Hold
44
– – ﹤0.01% 2631
2025
Q2 		$0 Sell
44
-3
-6% -$3 ﹤0.01% 2605
2025
Q1 		$0 Hold
47
– – ﹤0.01% 2590
2024
Q4 		$0 Sell
47
-16
-25% -$31 ﹤0.01% 2596
2024
Q3 		$0 Sell
63
-3
-5% -$5 ﹤0.01% 2600
2024
Q2 		$0 Buy
66
+41
+164% +$83 ﹤0.01% 2610
2024
Q1 		$0 Buy
25
+11
+79% +$64 ﹤0.01% 2597
2023
Q4 		$0 Sell
14
-1
-7% -$8 ﹤0.01% 2553
2023
Q3 		$0 Sell
15
-7
-32% -$80 ﹤0.01% 2541
2023
Q2 		$0 Hold
22
– – ﹤0.01% 2499
2023
Q1 		$0 Hold
22
– – ﹤0.01% 2423
2022
Q4 		$0 Sell
22
-2
-8% -$17 ﹤0.01% 2451
2022
Q3 		$0 Sell
24
-4
-14% -$23 ﹤0.01% 2415
2022
Q2 		$0 Sell
28
-8
-22% -$49 ﹤0.01% 2228
2022
Q1 		$0 Sell
36
-198
-85% -$2.28K ﹤0.01% 2340
2021
Q4 		$5K Buy
+234
New +$5.65K 0.01% 1329

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Covestor's PACB Position: Q2 2026 in Review

Covestor increased its Pacific Biosciences (PACB) stake by 242% in Q2 2026, buying an estimated $151 and bringing the position to 147 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

Covestor first reported a position in PACB in Q4 2021 and has held it in 19 quarters since. The position peaked at $5K in Q4 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Covestor held 147 shares of Pacific Biosciences worth $0 as of Q2 2026.
  • Covestor bought 104 Pacific Biosciences shares in Q2 2026, an estimated $151.
  • Pacific Biosciences made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2751 holding.
  • Covestor first reported a position in Pacific Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Pacific Biosciences position peaked at $5K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.